EMF-Portal | Literature search results

2014, Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL

Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma [med. app.]

Cancer Med 3 (3): 592-602

2014, Carlberg M, Hardell L

[details] Decreased Survival of Glioma Patients with Astrocytoma Grade IV (Glioblastoma Multiforme) Associated with Long-Term Use of Mobile and Cordless Phones [epidem.]

Int J Environ Res Public Health 11 (10): 10790-10805

2014, Akhavan-Sigari R, Baf MM, Ariabod V, Rohde V, Rahighi S

[details] Connection between Cell Phone use, p53 Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses [med./bio.]

Rare Tumors 6 (3): 5350

2014, Morgan LL, Kesari S, Davis DL

[details] Why children absorb more microwave radiation than adults: The consequences [review]

J Microsc Ultrastruct 2 (4): 197-204

2014, Turner SG, Gergel T, Wu H, Lacroix M, Toms SA

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM-100A system [med. app.]

World J Surg Oncol 12: 162

2014, Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS

[details] The epidemiology of glioma in adults: a "state of the science" review [review]

Neuro Oncol 16 (7): 896-913

2014, Teodori L, Giovanetti A, Albertini MC, Rocchi M, Perniconi B, Valente MG, Coletti D

Static magnetic fields modulate X-ray-induced DNA damage in human glioblastoma primary cells [med./bio.]

J Radiat Res 55 (2): 218-227

2013, Butowski N, Wong ET, Mehta MP, Wilson LK

A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields [basics]

Semin Oncol 40 (6): S2-S4

2013, Marsh GM, Youk AO, Buchanich JM, Xu H, Downing S, Kennedy KJ, Esmen NA, Hancock RP, Lacey SE, Fleissner ML

Long-term health experience of jet engine manufacturing workers: VI: incidence of malignant central nervous system neoplasms in relation to estimated workplace exposures [epidem.]

J Occup Environ Med 55 (6): 654-675

2013, Mihailovic G, Markovic M, Zivkovic N, Mihailovic G, Markovic M, Berisavac I, Spaic M

[Epidemiological features of brain tumors] [foreign-language]

Srp Arh Celok Lek 141 (11-12): 823-829

2013, Roviello G, Petrioli R, Cerase A, Marsili S, Miracco C, Rubino G, Tini P

A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report [basics]

Case Rep Oncol 6 (3): 538-543

2013, Omuro A, DeAngelis LM

[details] Glioblastoma and other malignant gliomas: a clinical review [review]

JAMA 310 (17): 1842-1850

2013, Hardell L, Carlberg M

[details] Use of mobile and cordless phones and survival of patients with glioma [epidem.]

Neuroepidemiology 40 (2): 101-108

2013, Davies AM, Weinberg U, Palti Y

Tumor treating fields: a new frontier in cancer therapy [med. app.]

Ann N Y Acad Sci 1291: 86-95

2013, Villano JL, Williams LE, Watson KS, Ignatius N, Wilson MT, Valyi-Nagy T, Michals EA, Engelhard HH

Delayed response and survival from NovoTTF-100A in recurrent GBM [med. app.]

Med Oncol 30 (1): 338

2013, Nieder C

[Results of a randomized phase III study on treatment of recurrent glioblastoma: NovoTTF-100A versus chemotherapy] [comment]

Strahlenther Onkol 189 (1): 93-94

2013, Hardell L, Carlberg M, Hansson Mild K

[details] Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma [review]

Pathophysiology 20 (2): 85-110

2012, De Bonis P, Doglietto F, Anile C, Pompucci A, Mangiola A

Electric fields for the treatment of glioblastoma [med. app.]

Expert Rev Neurother 12 (10): 1181-1184

2012, Fonkem E, Wong ET

NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. app.]

Expert Rev Neurother 12 (8): 895-899

2012, Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality [med. app.]

Eur J Cancer 48 (14): 2192-2202

2012, Rulseh AM, Keller J, Klener J, Sroubek J, Dbaly V, Syrucek M, Tovarys F, Vymazal J

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields [med. app.]

World J Surg Oncol 10: 220

2012, Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Borea PA, Varani K

The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells [med./bio.]

PLoS One 7 (6): e39317

2011, Pless M, Weinberg U

[details] Tumor treating fields: concept, evidence and future [review]

Expert Opin Investig Drugs 20 (8): 1099-1106

2010, Farina M, Mariggio MA, Pietrangelo T, Stupak JJ, Morini A, Fano G

[details] ELF-EMFs induced effects on cell lines: controlling ELF generation in laboratory [med./bio.]

Progr Electromagn Res B (PIER B) 24: 131-153

2010, Baldi I, Huchet A, Bauchet L, Loiseau H

[Epidemiology of glioblastoma] [foreign-language]

Neurochirurgie 56 (6): 433-440